Citation Impact

Citing Papers

Chapter 1 Ginsenosides
2008 Standout
ASL mRNA-LNP Therapeutic for the Treatment of Argininosuccinic Aciduria Enables Survival Benefit in a Mouse Model
2023 StandoutNobel
Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult
2002 Standout
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
2006
Applying Adverse Outcome Pathways (AOPs) to support Integrated Approaches to Testing and Assessment (IATA)
2014 Standout
Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB1 receptors
2002
Sensitization to the Behavioral Effects of Cocaine: Modulation by Dynorphin and κ-Opioid Receptor Agonists
1997
Anxiolytic 2,3-benzodiazepines, their specific binding to the basal ganglia
2000
Catalpol prevents the loss of CA1 hippocampal neurons and reduces working errors in gerbils after ischemia-reperfusion injury
2005
Antinociception in the rat induced by a cold environment
1990
Maternal Immune Activation Alters Fetal Brain Development through Interleukin-6
2007 Standout
Delivery of Loperamide Across the Blood-Brain Barrier with Polysorbate 80-Coated Polybutylcyanoacrylate Nanoparticles
1997
Evidence for hypernociception induction following histamine H1 receptor activation in rodents
1998
Bowel Disorders
2016 Standout
Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens
2006 Standout
Drug Addiction, Dysregulation of Reward, and Allostasis
2001 Standout
Cognitive function in young and adult IL (interleukin)-6 deficient mice
2004
Descending control of pain
2002 Standout
Vanilloid VR1receptor is involved in rimonabant‐induced neuroprotection
2006
Central inhibition of sexual response in the male: a theoretical perspective
1999
Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues
1998
Function and Regulation of CREB Family Transcription Factors in the Nervous System
2002 Standout
Network pharmacology: the next paradigm in drug discovery
2008 Standout
Hypersexual Disorder: A Proposed Diagnosis for DSM-V
2009 Standout
Continued Trends in the Conditioned Place Preference Literature from 1992 to 1996, Inclusive, with a Cross-Indexed Bibliography
1998
Psychedelics
2016 Standout
REVIEW ON CPP: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade
2007 Standout
Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system
2001
Morphine metabolites
1997
Social and environmental influences on opioid sensitivity in rats: importance of an opioid’s relative efficacy at the mu-receptor
2005
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
2003 Standout
Solid lipid nanoparticles Production, characterization and applications
2001 Standout
Involvement of Opioid μ1-Receptors in Opioid-Induced Acceleration of Striatal and Limbic Dopaminergic Transmission
1999
Opiate Inhibition of Chemokine‐Induced Chemotaxis
1998
Neuromodulation and cortical function: modeling the physiological basis of behavior
1995
3,4 Methylenedioxymethamphetamine-induced conditioned place preference (CPP) is mediated by endocannabinoid system
2004
Chronic treatment with polychlorinated biphenyls (PCB) during pregnancy and lactation in the rat
2009
Role of the endocannabinoid system in MDMA intracerebral self‐administration in rats
2002
Addiction Motivation Reformulated: An Affective Processing Model of Negative Reinforcement.
2004 Standout
Clinical applications of hallucinogens: A review.
2016
Biological roles of glycans
2016 Standout
Pharmacokinetics and Pharmacodynamics of Sedatives and Analgesics in the Treatment of Agitated Critically Ill Patients
1997
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Biology of Natural Killer Cells
1989 Standout
Alterations in morphine-induced reward, locomotor activity, and thermoregulation in CREB-deficient mice
2005
Chronic treatment with a long-acting somatostatin analogue in a patient with intestinal carcinoid tumor: occurence of cholelithiasis
1990
Biodegradable polymeric nanoparticles as drug delivery devices
2001 Standout
An antisense oligodeoxynucleotide to the mu opioid receptor attenuates cocaine-induced behavioral sensitization and reward in mice
2006
Effects of chronic naltrexone treatment in rats on place preference and locomotor activation after acute administration of cocaethylene or ethanol plus cocaine
2004
Opioid-induced Delay in Gastric Emptying 
1997
Investigation into the role of histamine receptors in rodent antinociception
1996
Rehmannia glutinosa: Review of botany, chemistry and pharmacology
2008 Standout
Autoradiographic localization of dopamine D1 and D2 receptors in rat nucleus accumbens: Resistance to differential rearing conditions
1991 Standout
Δ9-Tetrahydrocannabinol-induced conditioned place preference and intracerebroventricular self-administration in rats
2004
The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin
2007 Standout
Capsaicin exhibits neuroprotective effects in a model of transient global cerebral ischemia in Mongolian gerbils
2005
Making “bad trips” good: How users of psychedelics narratively transform challenging trips into valuable experiences
2020 Standout
Neurobiology of Depression
2002 Standout
Neurotensin and Neuroendocrine Regulation
1997
Role of histamine in rodent antinociception
1994
The Mesolimbic Dopamine Reward Circuit in Depression
2006 Standout
Hormesis and medicine
2008
Behavioral and neurochemical characterization of α2A-adrenergic receptor knockout mice
2002 StandoutNobel
What we can do and what we cannot do with fMRI
2008 StandoutNature
Neuroprotection of catalpol in transient global ischemia in gerbils
2004
Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system
2001
The neural basis of psychedelic action
2022 Standout
LTP and LTD
2004 Standout
ω-Agatoxin IVA blocks spinal morphine/clonidine antinociceptive synergism
1996
Role of histamine H1 receptor in pain perception: a study of the receptor gene knockout mice
2000
Neurotransmitter systems involved in learning and memory in the rat: a meta-analysis based on studies of four behavioral tasks
2003
Histamine-induced modulation of nociceptive responses
1994
Applications of nanoparticles in biology and medicine
2004 Standout
Transient Receptor Potential Cation Channels in Disease
2007 Standout
Effects of hallucinogenic agents mescaline and phencyclidine on zebrafish behavior and physiology
2012
Addiction, Dopamine, and the Molecular Mechanisms of Memory
2000
Neurocircuitry of Addiction
2009 Standout
Modulation of morphine antinociception by antagonism of H2 receptors in the periaqueductal gray
1992
Rewarding effects of ethanol and cocaine in µ opioid receptor-deficient mice
2002
The debate over dopamine’s role in reward: the case for incentive salience
2006 Standout
Epidemiology of Gallbladder Disease: Cholelithiasis and Cancer
2012 Standout
Characterization of behavioral and endocrine effects of LSD on zebrafish
2010
Involvement of brain opiate receptors in the immune-suppressive effect of morphine.
1986
μ-Opioid Induction of Monocyte Chemoattractant Protein-1, RANTES, and IFN-γ-Inducible Protein-10 Expression in Human Peripheral Blood Mononuclear Cells
2000
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
2000 Standout
Bright Side of Lignin Depolymerization: Toward New Platform Chemicals
2018 Standout
Novel Qualitative Structure-Activity Relationships for the Antinociceptive Actions of H2 Antagonists, H3Antagonists and Derivatives
1997
Effects of ginsenosides on maze performance and brain choline acetyltransferase activity in scopolamine-treated young rats and aged rats
1997
The Thermal Grill Illusion: Unmasking the Burn of Cold Pain
1994 StandoutScience
Drug delivery and nanoparticles: Applications and hazards
2008 Standout
Small Molecules from Nature Targeting G-Protein Coupled Cannabinoid Receptors: Potential Leads for Drug Discovery and Development
2015
About Sleep's Role in Memory
2013 Standout
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
Differential Effects and Potential Adverse Outcomes of Ionic Silver and Silver Nanoparticles in Vivo and in Vitro
2014
Effects of Antisense to the α2A-Adrenoceptors Administered into the Region of the Locus Ceruleus on Behaviors in Plus-Maze and Sexual Behavior Tests in Sham-Operated and Castrated Male Rats
2001
Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization
1996
Opioids, Reward and Addiction: An Encounter of Biology, Psychology, and Medicine
1999
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
Opioid Complications and Side Effects
2008 Standout
The Essential Medicinal Chemistry of Curcumin
2017 Standout
Models of psychedelic drug action: modulation of cortical-subcortical circuits
2021
NEURAL MECHANISMS OF ADDICTION: The Role of Reward-Related Learning and Memory
2006 Standout
An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer
1996

Works of E. Gori being referenced

Behavioral and biochemical evidence of opioidergic involvement in cocaine sensitization.
1995
Effect of morphine and methadone acute treatment on immunological activity in mice: pharmacokinetic and pharmacodynamic correlates.
1994
Effect of salmon calcitonin on symptoms and urinary excretion of 5 hydroxyindoleacetic acid in the carcinoid syndrome.
1987
Naltrexone, Naltrindole, and CTOP Block Cocaine-Induced Sensitization to Seizures and Death
1997
Effect of centrally administered atropine and pirenzepine on radial arm maze performance in the rat
1991
Pertussis toxin pretreatment affects opiate/nonopiate and stress-induced analgesia differently
1991
Dose-dependent conditioned place preference produced by etonitazene and morphine
1992
Hallucinatory and rewarding effect of salvinorin A in zebrafish: κ-opioid and CB1-cannabinoid receptor involvement
2007
A novel method for self-administering addicting drugs intracerebroventricularly in a free-choice procedure
1998
Influence of pertussis toxin on thermic responses to morphine and neurotensin in rats
1992
Influence of ω-conotoxin on morphine analgesia and withdrawal syndrome in rats
1992
Relationship between morphine and etonitazene-induced working memory impairment and analgesia
1994
Polydeoxyribonucleotide (defibrotide) protects against post-ischemic behavioral, electroencephalographic and neuronal damage in the gerbil
1997
Involvement of κ-Opioid and Endocannabinoid System on Salvinorin A-Induced Reward
2007
In situ hybridization reveals specific increases in Gαs and Gαo mRNA in discrete brain regions of morphine-tolerant rats
1993
Intestinal effect of morphine 6-glucuronide: in vivo and in vitro characterization
1994
Central effect of yohimbine on sexual behavior in the rat
1990
Cold stress in the rat induces parallel changes in plasma and pituitary levels of endorphin and ACTH
1983
Comparison morphine and etonitazene in rat conditioned place preference (CPP) test
1992
Histamine as a central modulator of rat intestinal transit.
1989
Effect of intracerebroventricular administration of morphine upon intestinal motility in rat and its antagonism with naloxone
1977
Pertussis toxin modifies the effect of central morphine on rat intestinal motility
1990
Loperamide: Evidence of interaction with μ and δ opioid receptors
1983
Rankless by CCL
2026